Introducing Asphalion´s new website and its features. On this occasion, the different approaches to our complete range of services.

Introducing Asphalion´s new website and its features. On this occasion, the different approaches to our complete range of services.
July 7, 2022

Did you know that…?

Our brand new web features a section called “SERVICES”. You can navigate through our services by choosing different approaches: by department, by stage of development, by product or by region.

Today we will tell you more about our Medical and Scientific writing unit, focused on providing you with support to build the foundations of strong non-clinical and clinical developments.

Our team has academic research experience and a broad scientific background in non-clinical, clinical and CMC writing for different types of products, including innovative, biological, biotechnological and advanced therapies medicinal products. Asphalion’s expertise allows us to offer the best regulatory strategy for each project.

We can support you with all sort of regulatory related documentation required during the clinical development and registration. In addition to this, strategic inputs can be provided from the very beginning for segmentation/niche indication, conditional approval/fast track, orphan drug designations, preclinical and clinical development plans with minimal time-to-market, among others.

Among the many solutions of ad hoc Regulatory advice and strategic consultancy during product development we would highlight:

  • Regulatory roadmaps
  • Scientific Advice meetings
  • Orphan Drug Designation (ODD)
  • Paediatric Investigational Plan (PIP)
  • Regulatory tools
  • Support in Clinical Trial application in EU (preparation and submission)
  • Common Technical Dossier (CTD)

Have a look here for additional, more detailed information:

For further requests, you can send us an email at:

Search News & Events

  • Filter by category


Related news and events


During these two interactive days, leaders and world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and new trends. Discussion will focus on the actions, changes, evolutions and re-thinking needed to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to realise the improvements in both health and access.

NABIHEAL project | Website launch

NABIHEAL stands for “Antimicrobial Nanostructured Biomaterials for Complex Wound Healing” and is funded under the Horizon Europe Research and Innovation programme, and it aims at solving two unmet medical needs in complex wound healing: on the one hand, affordable treatments for wound infections and prevention of complications during wound healing, and on the other, a strategy to optimize the composition and efficacy of wound dressings.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting